Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

Arthur E Frankel; Wai C Yip; Eknath Naik; Hans C Hasselbalch

doi:10.1002/ccr3.4218

Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

Clin Case Rep. 2021 Jun 9;9(6):e04218. doi: 10.1002/ccr3.4218. eCollection 2021 Jun.

Authors

Arthur E Frankel¹, Wai C Yip¹, Eknath Naik¹, Hans C Hasselbalch²

Affiliations

¹ Department of Medicine West Palm Beach VA Medical Center West Palm Beach FL USA.
² Department of Hematology Zealand University Hospital Roskilde Denmark.

Abstract

A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.

Keywords: infectious diseases; oncology; pharmacology.

Publication types

Case Reports